Top VA analytical laboratory instrument manufacturing contractors
In the 12 months ending Oct 5, 2026, the Department of Veterans Affairs obligated $356.3M in net prime contract dollars under NAICS 334516, up 11.5% from $319.4M in the preceding 12 months. 172 prime contractors received positive obligations, and 9 of them accounted for 80% of that spend.
Prime contracts funded by the Department of Veterans Affairs. Latest 12 months: Oct 6, 2025 to Oct 5, 2026. Source: USAspending.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year (October to September).
Top VA contractors for NAICS 334516
Ranked by positive obligations in the latest 12 months. Share is of all positive obligations in this market.
| # | Contractor | Latest 12 mo | Prior 12 mo | Share | Rank change |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories Inc. | $88.5M | $79.4M | 24.8% | — |
| 2 | Beckman Coulter, Inc | $59.5M | $53.8M | 16.7% | — |
| 3 | Roche Diagnostics Corporation | $41.9M | $34.1M | 11.7% | — |
| 4 | Sysmex America, Inc | $24.1M | $26.5M | 6.7% | — |
| 5 | Siemens Healthcare Diagnostics Inc. | $22.3M | $22.5M | 6.2% | — |
| 6 | Cepheid | $19.1M | $17.7M | 5.3% | — |
| 7 | Biomerieux Inc | $15.6M | $6.3M | 4.3% | ▲ 2 |
| 8 | Government Scientific Source Inc | $12.4M | $11.8M | 3.5% | ▼ 1 |
| 9 | Werfen USA LLC | $9.1M | $9.2M | 2.5% | ▼ 1 |
| 10 | Quidelortho Sales Company, LLC | $5.2M | $3.2M | 1.4% | ▲ 6 |
| 11 | Leica Microsystems Inc. | $4.8M | $2.7M | 1.3% | ▲ 6 |
| 12 | Diagnostica Stago Inc | $4.0M | $3.9M | 1.1% | — |
| 13 | Polymedco LLC | $4.0M | $4.9M | 1.1% | ▼ 2 |
| 14 | Ortho-Clinical Diagnostics, Inc | $3.4M | $6.0M | 1.0% | ▼ 4 |
| 15 | Franklin Young International, Incorporated | $3.0M | $3.3M | 0.8% | ▼ 1 |
What changed in the last 12 months
Contractors with the largest change in reported obligations versus the preceding 12 months.
Largest gains
- Biomerieux Inc$6.3M → $15.6M (+$9.3M) · now #7
- Abbott Laboratories Inc.$79.4M → $88.5M (+$9.1M) · now #1
- Roche Diagnostics Corporation$34.1M → $41.9M (+$7.8M) · now #3
Largest declines
- Ortho-Clinical Diagnostics, Inc$6.0M → $3.4M (−$2.6M) · now #14
- Sysmex America, Inc$26.5M → $24.1M (−$2.4M) · now #4
- Becton, Dickinson and Company$3.3M → $2.0M (−$1.3M) · now #21
New to this market
33 contractors received their first obligations in this market (since FY2022) during the latest 12 months. The largest:
| Contractor | First obligation | Latest 12 mo |
|---|---|---|
| Upmc Presbyterian Shadyside | Jul 20, 2026 | $681K |
| Cytek Biosciences, Inc. | Jul 30, 2026 | $532K |
| Stumptown Research & Development, LLC | Jun 6, 2026 | $486K |
| Dynamic Devices LLC | Sep 25, 2026 | $304K |
| Safeware Inc | Sep 16, 2026 | $190K |
| Sentec, Inc. | Aug 5, 2026 | $168K |
| Precision X-RAY, Inc. | Sep 24, 2026 | $155K |
| Formulatrix, LLC | Jul 15, 2026 | $131K |
Where the money comes from
Funding sub-agencies within the Department of Veterans Affairs, latest 12 months. The funding organization can differ from the office that runs the requirement.
| Funding sub-agency | Latest 12 mo | Prior 12 mo | Change |
|---|---|---|---|
| Department of Veterans Affairs | $356.3M | $319.4M | Up $36.9M (11.5%) |
Potential recompetes
Large awards in this market whose current period of performance ends in the next 18 months. Treat these as research leads: options, extensions, and follow-on vehicles often change the timing.
| Award | Incumbent | Obligated | Current end |
|---|---|---|---|
| 36C24722F0199 | Roche Diagnostics Corporation COBAS MOLECULAR ANALYZER | $4.8M | Nov 30, 2026 |
| 36C24723C0005 | Biomerieux Inc BIOFIRE REAGENTS AND WARRANTIES | $12.9M | Dec 31, 2026 |
| 36C24722F0232 | Abbott Laboratories Inc. CHEMICAL ANALYZER | $10.1M | Feb 10, 2027 |
| 36C24724F0328 | Abbott Laboratories Inc. LAB CHEMISTRY SERVICES | $9.4M | May 31, 2027 |
| 36C25726N0213 | Beckman Coulter, Inc NTX VA AUTOMATION LINE (CHEMISTRY AND IMMUNOASSAY) CPRR BPA | $4.9M | May 31, 2027 |
| 36C24824F0003 | Roche Diagnostics Corporation COST PER TEST | $17.4M | Sep 30, 2027 |
| 36C26124F0252 | Abbott Molecular Inc. ABBOTT ALINITY M REAGENTS AND CONSUMABLES | $5.5M | Sep 30, 2027 |
| 36C24823P0007 | Cepheid COST PER TEST | $4.9M | Sep 30, 2027 |
| 36C24725N0006 | Abbott Laboratories Inc. CHEMISTRY ANALYZERS | $4.7M | Sep 30, 2027 |
| 36C24723F0518 | Cepheid REAGENTS | $4.1M | Nov 30, 2027 |
Common questions
Who are the top VA contractors for NAICS 334516?
In the latest 12 months, Abbott Laboratories Inc. ($88.5M), Beckman Coulter, Inc ($59.5M), Roche Diagnostics Corporation ($41.9M) received the most VA obligations for analytical laboratory instrument manufacturing.
How concentrated is this market?
The eight largest primes held 79.3% of positive obligations, and Abbott Laboratories Inc. alone held 24.8%. 33 contractors won their first obligations in this market during the latest 12 months.
Are any large VA NAICS 334516 contracts ending soon?
10 of the largest awards in this market reach their current end date in the next 18 months. The first is 36C24722F0199 (Roche Diagnostics Corporation, $4.8M obligated), ending Nov 30, 2026. An end date is a research lead, not a confirmed recompete: options and extensions often move it.
Related markets
NAICS 334516 across all agencies
HHS · NAICS 334516
$147.5MDoD · NAICS 334516
$127.8MCommerce · NAICS 334516
$62.9MUSDA · NAICS 334516
$59.7MDOJ · NAICS 334516
$36.6MDHS · NAICS 334516
$26.0MNASA · NAICS 334516
$22.6MEPA · NAICS 334516
$21.2MFigures are net obligations on prime contracts (award types A–D) from USAspending.gov, grouped by funding agency and the NAICS code on each award. Net obligations include deobligations and corrections, so they can differ from positive-obligation totals. See methodology.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.